BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $867,251 (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 44.0%

Value ($000) $381,265 Shares 10,840,630 Est. Cost $8.21 Unrealized +301.9%

MNST MONSTER BEVERAGE CORP NEW 34.3%

Value ($000) $297,370 Shares 4,679,308 Est. Cost $22.71 Unrealized +29.4%

IWM ISHARES TR 8.0%

Value ($000) $69,581 Shares 420,000 Est. Cost $109.78 Unrealized —

AXON AXON ENTERPRISE INC 6.4%

Value ($000) $55,697 Shares 760,062 Est. Cost $27.50 Unrealized +130.2%

LCTX LINEAGE CELL THERAPEUTICS IN 3.5%

Value ($000) $30,265 Shares 34,005,379 Est. Cost $1.03 Unrealized -19.2%

— ONCOCYTE CORPORATION 3.2%

Value ($000) $27,618 Shares 12,274,738 Est. Cost $3.31 Unrealized —

— AGEX THERAPEUTICS INC 0.6%

Value ($000) $5,455 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,840,630	$381,265	44.0%	$8.21	+301.9%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,679,308	$297,370	34.3%	$22.71	+29.4%	COM	61174X109
IWM	ISHARES TR	420,000	$69,581	8.0%	$109.78	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$55,697	6.4%	$27.50	+130.2%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$30,265	3.5%	$1.03	-19.2%	COM	53566P109
—	ONCOCYTE CORPORATION	12,274,738	$27,618	3.2%	$3.31	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$5,455	0.6%	$2.99	—	COM	00848H108